BWM
WST icon

Baron Wealth Management’s West Pharmaceutical WST Stock Holding History

Baron Wealth Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$421K Buy
1,174
+20
+2% +$6.12K 0.11% 134
2026
Q1 		$289K Sell
1,154
-20
-2% -$4.98K 0.09% 190
2025
Q4 		$323K Sell
1,174
-2
-0.2% -$547 0.1% 163
2025
Q3 		$309K Sell
1,176
-422
-26% -$103K 0.1% 153
2025
Q2 		$350K Sell
1,598
-259
-14% -$55.4K 0.12% 126
2025
Q1 		$416K Sell
1,857
-69
-4% -$19K 0.18% 89
2024
Q4 		$631K Buy
1,926
+35
+2% +$11K 0.3% 52
2024
Q3 		$568K Buy
1,891
+132
+8% +$40.4K 0.27% 55
2024
Q2 		$579K Sell
1,759
-11
-0.6% -$3.89K 0.3% 49
2024
Q1 		$700K Hold
1,770
– – 0.37% 38
2023
Q4 		$623K Hold
1,770
– – 0.34% 44
2023
Q3 		$664K Buy
1,770
+24
+1% +$9.28K 0.42% 30
2023
Q2 		$668K Buy
1,746
+7
+0.4% +$2.5K 0.42% 30
2023
Q1 		$603K Hold
1,739
– – 0.43% 32
2022
Q4 		$409K Buy
+1,739
New +$412K 0.31% 57

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Baron Wealth Management's WST Position: Q2 2026 in Review

Baron Wealth Management increased its West Pharmaceutical (WST) stake by 1.7% in Q2 2026, buying an estimated $6.12K and bringing the position to 1,174 shares worth $421K. The position accounts for 0.11% of the portfolio, ranked #134.

Baron Wealth Management first reported a position in WST in Q4 2022 and has held it in 15 quarters since. The position peaked at $700K in Q1 2024. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Baron Wealth Management held 1,174 shares of West Pharmaceutical worth $421K as of Q2 2026.
  • Baron Wealth Management bought 20 West Pharmaceutical shares in Q2 2026, an estimated $6.12K.
  • West Pharmaceutical made up 0.11% of Baron Wealth Management's portfolio in Q2 2026, its #134 holding.
  • Baron Wealth Management first reported a position in West Pharmaceutical in Q4 2022 and has held it in 15 quarters since.
  • Baron Wealth Management's West Pharmaceutical position peaked at $700K in Q1 2024.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Baron Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.